CYP7A1 and type 2 diabetes mellitus: Indeed, by targeting the mTOR pathway through cyp7a1‐mediated cholesterol‐to‐bile acid conversion, this flavonoid has been suggested to alleviate T2D‐induced hepatic lipid accumulation [43].